Transmedics Group, Inc.

Organ transplant device manufacturer Transmedics, Inc. announced on 7 September that the US Food and Drug Administration approved a PMA for the company’s OCS Heart System. The system is used to pres

Transmedics, Inc. has landed a July advisory committee date with the US Food and Drug Administration, during which the gastroenterology and urology devices panel will take up a PMA for the company’s

The US Food and Drug Administration approved one panel-track PMA supplement and no original PMAs during the week of 28 May to 3 June. The FDA approved a panel-track PMA supplement for TransMedics Inc

The US Food and Drug Administration approved a panel-track PMA supplement for TransMedics Inc. ’s Organ Care System (OCS) Lung, allowing it to be used for the preservation of donor lungs that would b